Advertisement
Advertisement
U.S. markets open in 4 hours 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
75.97-0.86 (-1.12%)
At close: 04:00PM EST
74.55 -1.42 (-1.87%)
After hours: 06:47PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close76.83
Open76.25
Bid0.00 x 1000
Ask0.00 x 1000
Day's Range75.50 - 77.28
52 Week Range60.10 - 85.00
Volume1,267,680
Avg. Volume1,478,708
Market Cap19.1B
Beta (5Y Monthly)1.12
PE Ratio (TTM)10.54
EPS (TTM)7.21
Earnings DateJan 25, 2022 - Jan 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est86.27
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
48% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HOLX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Hologic, Inc.
    Analyst Report: Hologic, Inc.Hologic develops and manufactures diagnostic and medical imaging systems, primarily serving the healthcare needs of women. In addition to equipment and device sales, it generates more than half of its revenue from consumables and disposables. Its customers include hospitals, imaging clinics, and private practices, as well as healthcare organizations and pharmaceutical companies.
    Rating
    Fair Value
    Economic Moat
    21 days agoArgus Research
View more
Advertisement
Advertisement